Insider Transactions in Q4 2025 at Milestone Pharmaceuticals Inc. (MIST)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 15
2025
|
Joseph Oliveto President and CEO |
SELL
Open market or private sale
|
Direct |
133,054
-22.79%
|
$266,108
$2.32 P/Share
|
|
Dec 15
2025
|
Amit Hasija CFO & EVP of Corp. Development |
SELL
Open market or private sale
|
Direct |
58,007
-38.67%
|
$116,014
$2.32 P/Share
|
|
Dec 15
2025
|
Lorenz Muller Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
53,566
-21.42%
|
$107,132
$2.32 P/Share
|
|
Dec 15
2025
|
Jeffrey Edward Nelson Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
58,007
-58.01%
|
$116,014
$2.32 P/Share
|
|
Dec 15
2025
|
David Bharucha Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
58,007
-35.51%
|
$116,014
$2.32 P/Share
|
|
Dec 12
2025
|
Joseph Oliveto President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
280,000
+32.42%
|
-
|
|
Dec 12
2025
|
Amit Hasija CFO & EVP of Corp. Development |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+40.0%
|
-
|
|
Dec 12
2025
|
Lorenz Muller Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+28.57%
|
-
|
|
Dec 12
2025
|
Jeffrey Edward Nelson Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+50.0%
|
-
|
|
Dec 12
2025
|
David Bharucha Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+37.97%
|
-
|
|
Dec 09
2025
|
Lorenz Muller Chief Commercial Officer |
SELL
Bona fide gift
|
Direct |
25,000
-14.28%
|
-
|